Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Solpin 750mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Drukst Biotech Private Limited

Salt Composition

Divalproex (750mg)

Overview Solpin 750mg Tablet ER

Epileptic seizures and migraine prophylaxis are key indications for the extended-release Solpin 750mg tablet. It's also sometimes prescribed for bipolar disorder management. Dosage and frequency are determined individually by your physician to optimize symptom control, and can be administered with or without food, consistently at the same time daily for maximum efficacy. Therapeutic effects typically manifest within a couple of weeks. Consistent use, as directed, is crucial; discontinuation or missed doses risk seizure recurrence and condition exacerbation; abrupt cessation is contraindicated. Common, usually mild, side effects encompass headache, blurred vision, nausea, vomiting, vertigo, fatigue, ataxia, easy bruising, and hypothermia. Persistent or troublesome side effects warrant medical consultation, while rash or redness necessitates immediate notification. Prolonged use can potentially reduce bone density (osteoporosis), elevating fracture risk. Suicidal ideation or behavior is a rare but serious potential adverse effect, requiring prompt medical attention if experienced. Prior heart disease, renal or hepatic impairment, urinary retention, depression, or suicidal tendencies must be disclosed before initiating therapy. Drug interactions are possible; inform your doctor of all concurrent medications to ensure safety. Pregnant individuals should consult their physician before initiating or altering Solpin 750mg usage. Alcohol consumption should be avoided due to the increased risk of side effects and seizures. Regular blood tests may be required for dose monitoring, both pre- and post-treatment commencement.

Primary Ingredients of Solpin 750mg Tablet ER

No text was provided to rewrite. Please provide the text you wish to have rephrased.

Uses of Solpin 750mg Tablet ER

Managing epileptic seizures and bipolar disorder; migraine prophylaxis.

Major Benefits of Solpin 750mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solpin 750mg Extended-Release Tablets can be consumed with or without food, however, consistent daily timing is recommended.

Common Side effects of Solpin 750mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Solpin 750mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Solpin 750mg Extended-Release Tablets can be consumed with or without food, though consistent timing is recommended.

How Solpin 750mg Tablet ER works:

Epileptic seizures are managed by Solpin 750mg Extended-Release tablets, an anticonvulsant that reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Solpin 750mg extended-release tablets and alcohol may result in increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Solpin 750mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Solpin 750mg tablets are considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Solpin 750mg tablets can induce adverse reactions that might impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Solpin 750mg tablets pose no safety concerns for patients with renal impairment, and no dosage modification is necessary.

LiverLiverUNSAFE

Extended-release Solpin 750mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Solpin 750mg Tablet ER :

Should you forget a Solpin 750mg Extended-Release Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Solpin 750mg Tablet ER

LabelValue
Chemical Category Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Anticonvulsant sodium channel blockers

FAQs on Solpin 750mg Tablet ER

Always consult your doctor before discontinuing Solpin 750mg Tablet ER. Withdrawal should be gradual, under medical supervision, to prevent symptom recurrence, including irritability, anxiety, dizziness, and tremors.
Solpin 750mg Extended-Release tablets may be used to stabilize mood in patients experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these mood changes.
Solpin 750mg ER tablets can cause weight gain, possibly from increased appetite. Manage your diet and exercise to minimize this risk. Consult your doctor about any weight concerns.
Solpin 750mg Extended-Release Tablets can cause drowsiness. Refrain from driving or activities requiring alertness until you understand its effects on you.
Hair loss is a possible, temporary side effect of Solpin 750mg ER tablets, often related to dosage. Contact your doctor if this side effect concerns you or continues.
Solpin 750mg ER tablets can cause liver damage, particularly within the first six months of treatment. Symptoms may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of skin or eyes). Liver function tests are crucial before starting and regularly during the initial six months, especially for at-risk individuals or those with pre-existing liver conditions.
Refrain from drinking alcohol while taking Solpin 750mg Extended-Release Tablets. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Solpin 750mg ER treatment, your doctor might order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to minimize bleeding risks. Liver function tests are also recommended beforehand, and regular monitoring during the first six months, especially for high-risk individuals or those with a history of liver problems, is advised.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result necessitates immediate medication cessation.
Solpin 750mg ER tablet overdose can lead to headaches, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Symptoms may also include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Solpin 750mg Tablet ER
62
MRP 75
17% off